Albee Messing

Active 1981–2025

81
Papers
18,100
Citations
73
h-index
78
i10-index

Citations

Citations per year for Albee Messing1981: 1 citations1983: 2 citations1984: 2 citations1985: 8 citations1986: 22 citations1987: 37 citations1988: 33 citations1989: 21 citations1990: 19 citations1991: 27 citations1992: 27 citations1993: 9 citations1994: 21 citations1995: 18 citations1996: 30 citations1997: 21 citations1998: 49 citations1999: 80 citations2000: 76 citations2001: 99 citations2002: 113 citations2003: 170 citations2004: 146 citations2005: 150 citations2006: 173 citations2007: 176 citations2008: 199 citations2009: 207 citations2010: 182 citations2011: 170 citations2012: 172 citations2013: 171 citations2014: 164 citations2015: 178 citations2016: 143 citations2017: 162 citations2018: 117 citations2019: 399 citations2020: 383 citations2021: 539 citations2022: 530 citations2023: 417 citations2024: 579 citations2025: 307 citations2026: 8 citations1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,704 citing papers, 32.8% of this breakdownChina: 613 citing papers, 7.4% of this breakdownUnited Kingdom: 594 citing papers, 7.2% of this breakdownGermany: 541 citing papers, 6.6% of this breakdownItaly: 355 citing papers, 4.3% of this breakdownCanada: 323 citing papers, 3.9% of this breakdownFrance: 304 citing papers, 3.7% of this breakdownSpain: 288 citing papers, 3.5% of this breakdownJapan: 250 citing papers, 3% of this breakdownNetherlands: 178 citing papers, 2.2% of this breakdownSwitzerland: 174 citing papers, 2.1% of this breakdownSweden: 169 citing papers, 2% of this breakdown
0%32.8%Other 21.3%

Fields

  • Neuroscience35.5%
  • Biochemistry, Genetics and Molecular Biology34.2%
  • Medicine27.3%
  • Immunology and Microbiology1.3%
  • Engineering0.4%
  • Psychology0.3%
  • Other1%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms8.2%
  • Neurogenesis and neuroplasticity mechanisms5.6%
  • Neuroscience and Neuropharmacology Research5.5%
  • Alzheimer's disease research and treatments3.2%
  • Nerve injury and regeneration2.7%
  • Ion channel regulation and function1.9%
  • Other72.9%

Coauthors

All papers

Open in search
  1. Reactive astrocyte nomenclature, definitions, and future directions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip G. Haydon, Dieter Henrik Heiland, Elly M. Hol, Matthew G. Holt, Masamitsu Iino, Ksenia V. Kastanenka, Helmut Kettenmann, Baljit S. Khakh, Schuichi Koizumi, C. Justin Lee, Shane A. Liddelow, Brian A. MacVicar, Pierre J. Magistretti, Albee Messing, Anusha Mishra, Anna V. Molofsky, Keith K. Murai, Christopher M. Norris, Seiji Okada, Stéphane H. R. Oliet, João Filipe Oliveira, Aude Panatier, Vladimir Parpura, Marcela Pekna, Milos Pekny, Luc Pellerin, Gertrudis Perea, Beatriz Gomez Perez‐Nievas, Frank W. Pfrieger, Kira E. Poskanzer, Francisco J. Quintana, Richard M. Ransohoff, Miriam Riquelme‐Perez, Stefanie Robel, Christine R. Rose, Jeffrey D. Rothstein, Nathalie Rouach, David H. Rowitch, Alexey Semyanov, Swetlana Sirko, Harald Sontheimer, Raymond A. Swanson, Javier Vitórica, I. Wanner, Levi B. Wood, Jiaqian Wu, Binhai Zheng, Eduardo R. Zimmer, Robert Zorec, Michael V. Sofroniew, Alexei Verkhratsky - Nature Neuroscience 2021 cited by 2,366

  2. Astrocytes: a central element in neurological diseases

    Authors: , , , , , , , , - Acta Neuropathologica 2015 cited by 760

  3. GFAP promoter elements required for region‐specific and astrocyte‐specific expression

    Authors: , , , - Glia 2008 cited by 415

  4. Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis

    Authors: , , , , - Journal of Neuroscience 2008 cited by 475

  5. Regulation of GFAP Expression

    Authors: , - ASN NEURO 2021 cited by 123

  6. Cre/loxP‐mediated inactivation of the murine Pten tumor suppressor gene

    Authors: , , , , , , , - genesis 2002 cited by 397

  7. hGFAP‐cre transgenic mice for manipulation of glial and neuronal function in vivo

    Authors: , , , , , - genesis 2001 cited by 669

  8. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease

    Authors: , , , , , - Nature Genetics 2001 cited by 686

  9. GFAP at 50

    Authors: , - ASN NEURO 2020 cited by 116

  10. Deletion of the KV1.1 Potassium Channel Causes Epilepsy in Mice

    Authors: , , , , , , , , - Neuron 1998 cited by 601

  11. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma

    Authors: , , , , , , , - Cancer Cell 2005 cited by 545

  12. GFAP mutations, age at onset, and clinical subtypes in Alexander disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yoshihisa Takiyama, K Wakabayashi, J. R. Gorospe, Adeline Vanderver - Neurology 2011 cited by 256

  13. Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment

    Authors: , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 55

  14. GFAP promoter directs astrocyte-specific expression in transgenic mice

    Authors: , , , , - Journal of Neuroscience 1994 cited by 497

  15. Alexander Disease

    Authors: , , , , - Journal of Neuroscience 2012 cited by 253

  16. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice.

    Authors: , , , , , - 1998 cited by 246

  17. Live Astrocytes Visualized by Green Fluorescent Protein in Transgenic Mice

    Authors: , , , , , - Developmental Biology 1997 cited by 366

  18. Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways

    Authors: , , , , , , , - Human Molecular Genetics 2008 cited by 170

  19. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy

    Authors: , , , , , , , , , , , - Nature 2002 cited by 579

  20. P0‐Cre Transgenic Mice for Inactivation of Adhesion Molecules in Schwann Cells

    Authors: , , , , , - Annals of the New York Academy of Sciences 1999 cited by 210

  21. Alexander Disease-Associated Glial Fibrillary Acidic Protein Mutations in Mice Induce Rosenthal Fiber Formation and a White Matter Stress Response

    Authors: , , - Journal of Neuroscience 2006 cited by 157

  22. Brain-specific Phgdh Deletion Reveals a Pivotal Role for l-Serine Biosynthesis in Controlling the Level of d-Serine, an N-methyl-d-aspartate Receptor Co-agonist, in Adult Brain

    Authors: , , , , , , , , , , , , , , , , - Journal of Biological Chemistry 2010 cited by 145

  23. Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoform

    Authors: , , , , , , , , , , , , , , , , , - Human Mutation 2020 cited by 24

  24. Conditional disruption of β1 integrin in Schwann cells impedes interactions with axons

    Authors: , , , , , , , , , , , - The Journal of Cell Biology 2002 cited by 329